MRD / Regn No. : SG004597 Date : 22/06/2026
Patient Name : A Das Age & Gender : 52 Yrs. / Female
Contact No. : 8045691011 UHID :
Ht / Wt / BMI : 154 / 41 / 17.29 BP S / BP D : 123 / 80
Allergies : NKA Referred By :
   
Problem List : TYPE 2 DIABETES (22/Jun/2019) | MODERATE NPDR (22/Jun/2026) |
Salient Investigations : CREATININE: 0.9 | EGFR EGLOMERULAR FILTRATION RATE: 70.30 mL/min/1.73m2 | FASTING PLASMA GLUCOSE (FPG): 475 mg/dL | HB HEMOGLOBIN: 11.6 g/dL | HBA1C GLYCOSYLATED HEMOGLOBIN: 14 % | LDL LOW DENSITY LIPOPROTEIN: 83 mg/dL | MICROALBUMIN CREATININE RATIO: 27.5 mcg/mg
S# Generic (Trade) Name Route Dosage Usage Duration
1 GLICLAZIDE 80 MG + METFORMIN 500 MG
GLIZID M 		PO 1-0-1 BEFORE BREAKFAST AND DINNER
 TILL NEXT VISIT
2 ANTIHYPERGLYCEMIC DAPAGLIFLOZIN 10 MG + LINAGLIPTIN 5 MG
ZEXRIDA L 		PO 1-0-0 BEFORE BREAKFAST
 TILL NEXT VISIT
3 INJECTION GLARGINE (INJ U100)
LANTUS
Medicine For GLUCOSE CONTROL 		SQ 0-0-18 AT BEDTIME
 TILL NEXT VISIT
MAY CAUSE HYPOGLYCEMIA
4 ATORVASTATIN 20
TONACT 		PO 0-0-1 BEFORE DINNER
 TILL NEXT VISIT
       
Refill : 0 / Substitution:    
Education :
Next Visit : 22/Dec/2026
Tests Suggested For Next Visit : SMBG,HBA1C-HPLC METHOD,UACR:SPOT SAMPLE
   
   
User-Profile-Image
Dr. Samit Ghosal
MD (GM), Diploma in Diabetes Cardiff University, MSc (Diabetes Care) Glamorgan University, Diploma in Endocrinology Glamorgan University (USW), SCOPE certification in obesity management
West Bengal / 54020

This is a Computer generated Prescription

Powered By: